IBDEI02P ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,501,0)
 ;;=T1016^^5^66^1^^^^1
 ;;^UTILITY(U,$J,358.3,501,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,501,1,2,0)
 ;;=2^Case Management
 ;;^UTILITY(U,$J,358.3,501,1,3,0)
 ;;=3^T1016
 ;;^UTILITY(U,$J,358.3,502,0)
 ;;=I50.9^^6^67^1
 ;;^UTILITY(U,$J,358.3,502,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,502,1,3,0)
 ;;=3^CHF,Unspec
 ;;^UTILITY(U,$J,358.3,502,1,4,0)
 ;;=4^I50.9
 ;;^UTILITY(U,$J,358.3,502,2)
 ;;=^5007251
 ;;^UTILITY(U,$J,358.3,503,0)
 ;;=I10.^^6^67^2
 ;;^UTILITY(U,$J,358.3,503,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,503,1,3,0)
 ;;=3^HTN,Essential
 ;;^UTILITY(U,$J,358.3,503,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,503,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,504,0)
 ;;=E78.4^^6^67^3
 ;;^UTILITY(U,$J,358.3,504,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,504,1,3,0)
 ;;=3^Hyperlipidemia,Other
 ;;^UTILITY(U,$J,358.3,504,1,4,0)
 ;;=4^E78.4
 ;;^UTILITY(U,$J,358.3,504,2)
 ;;=^5002968
 ;;^UTILITY(U,$J,358.3,505,0)
 ;;=E78.5^^6^67^4
 ;;^UTILITY(U,$J,358.3,505,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,505,1,3,0)
 ;;=3^Hyperlipidemia,Unspec
 ;;^UTILITY(U,$J,358.3,505,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,505,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,506,0)
 ;;=Z51.5^^6^68^7
 ;;^UTILITY(U,$J,358.3,506,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,506,1,3,0)
 ;;=3^Palliative Care Encounter
 ;;^UTILITY(U,$J,358.3,506,1,4,0)
 ;;=4^Z51.5
 ;;^UTILITY(U,$J,358.3,506,2)
 ;;=^5063063
 ;;^UTILITY(U,$J,358.3,507,0)
 ;;=Z99.81^^6^68^4
 ;;^UTILITY(U,$J,358.3,507,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,507,1,3,0)
 ;;=3^Dependence on Supplemental Oxygen
 ;;^UTILITY(U,$J,358.3,507,1,4,0)
 ;;=4^Z99.81
 ;;^UTILITY(U,$J,358.3,507,2)
 ;;=^5063760
 ;;^UTILITY(U,$J,358.3,508,0)
 ;;=Z71.89^^6^68^2
 ;;^UTILITY(U,$J,358.3,508,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,508,1,3,0)
 ;;=3^Counseling,Other Specified
 ;;^UTILITY(U,$J,358.3,508,1,4,0)
 ;;=4^Z71.89
 ;;^UTILITY(U,$J,358.3,508,2)
 ;;=^5063253
 ;;^UTILITY(U,$J,358.3,509,0)
 ;;=Z65.9^^6^68^8
 ;;^UTILITY(U,$J,358.3,509,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,509,1,3,0)
 ;;=3^Problem Related to Unspec Psychosocial Circumstances
 ;;^UTILITY(U,$J,358.3,509,1,4,0)
 ;;=4^Z65.9
 ;;^UTILITY(U,$J,358.3,509,2)
 ;;=^5063186
 ;;^UTILITY(U,$J,358.3,510,0)
 ;;=Z23.^^6^68^6
 ;;^UTILITY(U,$J,358.3,510,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,510,1,3,0)
 ;;=3^Immunization Encounter
 ;;^UTILITY(U,$J,358.3,510,1,4,0)
 ;;=4^Z23.
 ;;^UTILITY(U,$J,358.3,510,2)
 ;;=^5062795
 ;;^UTILITY(U,$J,358.3,511,0)
 ;;=Z51.89^^6^68^9
 ;;^UTILITY(U,$J,358.3,511,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,511,1,3,0)
 ;;=3^Specified Aftercare Encounter
 ;;^UTILITY(U,$J,358.3,511,1,4,0)
 ;;=4^Z51.89
 ;;^UTILITY(U,$J,358.3,511,2)
 ;;=^5063065
 ;;^UTILITY(U,$J,358.3,512,0)
 ;;=Z71.9^^6^68^3
 ;;^UTILITY(U,$J,358.3,512,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,512,1,3,0)
 ;;=3^Counseling,Unspec
 ;;^UTILITY(U,$J,358.3,512,1,4,0)
 ;;=4^Z71.9
 ;;^UTILITY(U,$J,358.3,512,2)
 ;;=^5063254
 ;;^UTILITY(U,$J,358.3,513,0)
 ;;=Z51.81^^6^68^10
 ;;^UTILITY(U,$J,358.3,513,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,513,1,3,0)
 ;;=3^Therapeutic Drug Level Monitoring
 ;;^UTILITY(U,$J,358.3,513,1,4,0)
 ;;=4^Z51.81
 ;;^UTILITY(U,$J,358.3,513,2)
 ;;=^5063064
 ;;^UTILITY(U,$J,358.3,514,0)
 ;;=Z02.89^^6^68^1
 ;;^UTILITY(U,$J,358.3,514,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,514,1,3,0)
 ;;=3^Administrative Examination Encounter
 ;;^UTILITY(U,$J,358.3,514,1,4,0)
 ;;=4^Z02.89
 ;;^UTILITY(U,$J,358.3,514,2)
 ;;=^5062645
 ;;^UTILITY(U,$J,358.3,515,0)
 ;;=Z71.3^^6^68^5
 ;;^UTILITY(U,$J,358.3,515,1,0)
 ;;=^358.31IA^4^2
